Sign Out
In common with all neuromuscular-blocking agents, Notrixum should be used during pregnancy only if the potential benefit to the mother outweighs any potential risk to the fetus.
Notrixum is suitable for maintenance of muscle relaxation during caesarean section as it does not cross the placenta in clinically significant amounts following recommended doses.
It is not known whether Notrixum is excreted in human milk.
Atracurium besylate is inactivated by high pH and so must not be mixed in the same syringe with thiopentone or any alkaline agent.
